Literature DB >> 16443214

Ca2+-activated K+ (KCa) channels are involved in the relaxations elicited by sildenafil in penile resistance arteries.

Dolores Prieto1, Luis Rivera, Sara Benedito, Paz Recio, Nuria Villalba, Medardo Hernández, Albino García-Sacristán.   

Abstract

The aim of the present study was to evaluate the role of K+ channels in the vasorelaxant effect of the phosphodiesterase 5 inhibitor, sildenafil, in isolated horse penile resistance arteries mounted in microvascular myographs. In phenylephrine-precontracted arteries, sildenafil elicited potent relaxations which were markedly reduced by raising extracellular K+, by the non-selective blocker of Ca2+-activated K+ channels (KCa), tetraethylammonium and by the blocker of large- and intermediate-conductance KCa channels, charybdotoxin. Sildenafil relaxant responses were also reduced by the selective inhibitor of large conductance KCa (BK(Ca)) channels iberiotoxin, but not by the blocker of small conductance KCa channels apamin. The inhibitor of the cGMP-dependent protein kinase (PKG), Rp-8-Br-PET-cGMPS, reduced the relaxations elicited by sildenafil but combined treatment with iberiotoxin and Rp-8-Br-PET-cGMPS did not further inhibit these relaxations, compared to the effect of either blocker alone. Iberiotoxin also shifted to the right the relaxations elicited by both the NO donor, S-nitrosoacetyl-D,L-penicillamine (SNAP) and the adenylate cyclase activator forskolin; treatment with both iberiotoxin and Rp-8-Br-PET-cGMPS did cause an additional inhibition. The present results demonstrate that the relaxant effect of sildenafil and NO in penile resistance arteries is due in part to activation of BK(Ca) channels through a PKG-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443214     DOI: 10.1016/j.ejphar.2005.12.033

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Mechanisms involved in the nitric oxide-induced vasorelaxation in porcine prostatic small arteries.

Authors:  Vítor S Fernandes; Ana Martínez-Sáenz; Paz Recio; Ana S F Ribeiro; Ana Sánchez; María Pilar Martínez; Ana Cristina Martínez; Albino García-Sacristán; Luis M Orensanz; Dolores Prieto; Medardo Hernández
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-07-12       Impact factor: 3.000

Review 2.  Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle.

Authors:  Manuel Morgado; Elisa Cairrão; António José Santos-Silva; Ignacio Verde
Journal:  Cell Mol Life Sci       Date:  2011-09-27       Impact factor: 9.261

3.  Signalling pathways involved in sildenafil-induced relaxation of human bladder dome smooth muscle.

Authors:  S Oger; D Behr-Roussel; D Gorny; T Lebret; P Validire; X Cathelineau; L Alexandre; F Giuliano
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.

Authors:  R González-Corrochano; Jm La Fuente; P Cuevas; A Fernández; Mx Chen; I Sáenz de Tejada; J Angulo
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

5.  NS11021, a novel opener of large-conductance Ca(2+)-activated K(+) channels, enhances erectile responses in rats.

Authors:  A Kun; V V Matchkov; E Stankevicius; A Nardi; A D Hughes; H J Kirkeby; J Demnitz; U Simonsen
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

Review 6.  The Human Microcirculation: Regulation of Flow and Beyond.

Authors:  David D Gutterman; Dawid S Chabowski; Andrew O Kadlec; Matthew J Durand; Julie K Freed; Karima Ait-Aissa; Andreas M Beyer
Journal:  Circ Res       Date:  2016-01-08       Impact factor: 17.367

7.  Inhibition by sildenafil of contractility of isolated non-pregnant human myometrium.

Authors:  Aruldhas Blessed Winston; Kaysina Vazhudhi; Sumalya Sen; Elsy Thomas; Santhosh Benjamin; Jacob Peedicayil
Journal:  J Pharmacol Pharmacother       Date:  2015 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.